Cargando…
Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Turkish League Against Rheumatism
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689017/ https://www.ncbi.nlm.nih.gov/pubmed/38046252 http://dx.doi.org/10.46497/ArchRheumatol.2023.9212 |
| _version_ | 1785152281219432448 |
|---|---|
| author | Lee, Kyung-ann Jung, Seung-hwan Kim, Jong-sun Kim, Hyun-sook |
| author_facet | Lee, Kyung-ann Jung, Seung-hwan Kim, Jong-sun Kim, Hyun-sook |
| author_sort | Lee, Kyung-ann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10689017 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Turkish League Against Rheumatism |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106890172023-12-01 Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study Lee, Kyung-ann Jung, Seung-hwan Kim, Jong-sun Kim, Hyun-sook Arch Rheumatol Letter Turkish League Against Rheumatism 2022-11-04 /pmc/articles/PMC10689017/ /pubmed/38046252 http://dx.doi.org/10.46497/ArchRheumatol.2023.9212 Text en Copyright © 2023, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letter Lee, Kyung-ann Jung, Seung-hwan Kim, Jong-sun Kim, Hyun-sook Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title | Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title_full | Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title_fullStr | Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title_full_unstemmed | Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title_short | Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study |
| title_sort | comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary raynaud’s phenomenon: an open-label, randomized, prospective pilot study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689017/ https://www.ncbi.nlm.nih.gov/pubmed/38046252 http://dx.doi.org/10.46497/ArchRheumatol.2023.9212 |
| work_keys_str_mv | AT leekyungann comparisonoftheefficacyandsafetyofoligomericproanthocyanidinsandnifedipineinpatientswithprimaryraynaudsphenomenonanopenlabelrandomizedprospectivepilotstudy AT jungseunghwan comparisonoftheefficacyandsafetyofoligomericproanthocyanidinsandnifedipineinpatientswithprimaryraynaudsphenomenonanopenlabelrandomizedprospectivepilotstudy AT kimjongsun comparisonoftheefficacyandsafetyofoligomericproanthocyanidinsandnifedipineinpatientswithprimaryraynaudsphenomenonanopenlabelrandomizedprospectivepilotstudy AT kimhyunsook comparisonoftheefficacyandsafetyofoligomericproanthocyanidinsandnifedipineinpatientswithprimaryraynaudsphenomenonanopenlabelrandomizedprospectivepilotstudy |